[HTML][HTML] Anti-LL37 antibodies are present in psoriatic arthritis (PsA) patients: new biomarkers in PsA
Psoriatic arthritis (PsA) is a chronic inflammatory arthritis associated with psoriasis. A third of
psoriatic patients develop PsA via unknown mechanisms. No reliable diagnostic markers …
psoriatic patients develop PsA via unknown mechanisms. No reliable diagnostic markers …
Anti-LL37 Antibodies Are Present in Psoriatic Arthritis (PsA) Patients: New Biomarkers in PsA
L Frasca, R Palazzo, MS Chimenti… - … in Immunology (Web), 2018 - jglobal.jst.go.jp
Anti-LL37 Antibodies Are Present in Psoriatic Arthritis (PsA) Patients: New Biomarkers in
PsA | Article Information | J-GLOBAL Art J-GLOBAL ID:201902215346879450 Reference …
PsA | Article Information | J-GLOBAL Art J-GLOBAL ID:201902215346879450 Reference …
Anti-LL37 Antibodies Are Present in Psoriatic Arthritis (PsA) Patients: New Biomarkers in PsA
L Frasca, R Palazzo, MS Chimenti… - Frontiers in …, 2018 - pubmed.ncbi.nlm.nih.gov
Psoriatic arthritis (PsA) is a chronic inflammatory arthritis associated with psoriasis. A third of
psoriatic patients develop PsA via unknown mechanisms. No reliable diagnostic markers …
psoriatic patients develop PsA via unknown mechanisms. No reliable diagnostic markers …
[HTML][HTML] Anti-LL37 Antibodies Are Present in Psoriatic Arthritis (PsA) Patients: New Biomarkers in PsA
L Frasca, R Palazzo, MS Chimenti… - Frontiers in …, 2018 - ncbi.nlm.nih.gov
Psoriatic arthritis (PsA) is a chronic inflammatory arthritis associated with psoriasis. A third of
psoriatic patients develop PsA via unknown mechanisms. No reliable diagnostic markers …
psoriatic patients develop PsA via unknown mechanisms. No reliable diagnostic markers …
Anti-LL37 antibodies are present in psoriatic arthritis (PsA) patients: New biomarkers in PsA
L Frasca, R Palazzo, M Chimenti… - FRONTIERS IN …, 2018 - art.torvergata.it
Psoriatic arthritis (PsA) is a chronic inflammatory arthritis associated with psoriasis. A third of
psoriatic patients develop PsA via unknown mechanisms. No reliable diagnostic markers …
psoriatic patients develop PsA via unknown mechanisms. No reliable diagnostic markers …
[引用][C] Anti-LL37 Antibodies Are Present in Psoriatic Arthritis (PsA) Patients: New Biomarkers in PsA
L Frasca, R Palazzo, MS Chimenti, S Alivernini… - Frontiers in …, 2018 - cir.nii.ac.jp
Anti-LL37 Antibodies Are Present in Psoriatic Arthritis (PsA) Patients: New Biomarkers in PsA.
L Frasca, R Palazzo, MS Chimenti… - Frontiers in …, 2018 - europepmc.org
Psoriatic arthritis (PsA) is a chronic inflammatory arthritis associated with psoriasis. A third of
psoriatic patients develop PsA via unknown mechanisms. No reliable diagnostic markers …
psoriatic patients develop PsA via unknown mechanisms. No reliable diagnostic markers …
[引用][C] Anti-LL37 Antibodies Are Present in Psoriatic Arthritis (PsA) Patients: New Biomarkers in PsA.
L Frasca, R Palazzo, M Chimenti… - FRONTIERS IN …, 2018 - iris.hunimed.eu
Anti-LL37 antibodies are present in psoriatic arthritis (PsA) patients: New biomarkers in PsA
L Frasca, R Palazzo, M Chimenti… - FRONTIERS IN …, 2018 - iris.uniroma1.it
Psoriatic arthritis (PsA) is a chronic inflammatory arthritis associated with psoriasis. A third of
psoriatic patients develop PsA via unknown mechanisms. No reliable diagnostic markers …
psoriatic patients develop PsA via unknown mechanisms. No reliable diagnostic markers …
Anti-LL37 antibodies are present in psoriatic arthritis (PsA) patients: New biomarkers in PsA
L Frasca, R Palazzo, MS Chimenti… - FRONTIERS IN …, 2018 - publicatt.unicatt.it
Psoriatic arthritis (PsA) is a chronic inflammatory arthritis associated with psoriasis. A third of
psoriatic patients develop PsA via unknown mechanisms. No reliable diagnostic markers …
psoriatic patients develop PsA via unknown mechanisms. No reliable diagnostic markers …